Home › Funds › Affinity Asset Advisors, LLC › ROIV

Affinity Asset Advisors, LLC position in ROIV

ROIVANT SCIENCES LTD · Health Care

Affinity Asset Advisors, LLC reported holding 3,200,000 shares of ROIV (ROIVANT SCIENCES LTD) in its Q3 2026 13F filing — a position valued at US$117.0M, representing 5.45% of its reported portfolio and ranking #2 among its reported holdings. Affinity Asset Advisors, LLC has disclosed ROIV holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.20M sh
Reported value held$117.02M
Portfolio Weight5.45%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Affinity Asset Advisors, LLC's ROIV position evolved

Affinity Asset Advisors, LLC first disclosed a stake in ROIV in Q3 2023 at 150,000 shares (US$1.8M). The position peaked in Q2 2026 at 3,750,000 shares, worth US$132.7M. Across 12 filings, Affinity Asset Advisors, LLC increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 3,200,000 shares valued at US$117.0M — a reduction of -550,000 shares quarter over quarter.. Notable position changes include a 233% increase in Q4 2023 (shares fell 6% over the following quarter), a 167% increase in Q2 2025 (shares rose 34% over the following quarter), a 112% increase in Q4 2025 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 150.00K $1.75M New
Q4 2023 500.00K $5.62M Add
Q1 2024 500.00K $5.27M Hold
Q2 2024 351.59K $3.72M Reduce
Q3 2024 201.59K $2.33M Reduce
Q1 2025 150.00K $1.51M New
Q2 2025 400.00K $4.51M Add
Q3 2025 800.00K $12.10M Add
Q4 2025 1.70M $36.89M Add
Q1 2026 2.80M $77.56M Add
Q2 2026 3.75M $132.71M Add
Q3 2026 3.20M $117.02M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ROIV and 13F data

ROIV (ROIVANT SCIENCES LTD) is a Health Care company. 60 other funds we track also report a position in ROIV — the largest reported positions include QVT Financial LP (US$839.6M), Farallon Capital Management (US$506.4M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$506.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ROIV

All ROIV fund holders →

FAQ

How long has Affinity Asset Advisors, LLC held ROIV?

Affinity Asset Advisors, LLC has disclosed ROIV holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is Affinity Asset Advisors, LLC's current position in ROIV?

As of Q3 2026, Affinity Asset Advisors, LLC holds 3.20M shares of ROIV (ROIVANT SCIENCES LTD), valued at $117.02M, representing 5.45% of its reported portfolio and ranking #2.

Has Affinity Asset Advisors, LLC been buying or selling ROIV?

In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC reduced its position in ROIV. The position peaked in Q2 2026 at 3.75M shares.

Which other funds hold ROIV?

Other major institutional holders of ROIV include QVT Financial LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.